Elanco’s Credelio Quattro-CA1 Receives the FDA’s Conditional Approval to Treat New World Screwworm Infestations in Dogs

Shots: The US FDA has granted conditional approval to Elanco's Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, & pyrantel) for the treatment of infestations caused by New World screwworm larvae (myiasis) in dogs Approval was based on a study showing that oral lotilaner achieved 100% efficacy against New World screwworm (Cochliomyia hominivorax) larvae within 24hrs. at the…

ByRidhi RastogiDecember 19, 2025

NEWS

Elanco’s Credelio CAT (Lotilaner) Receives the US FDA’s EUA Against New World Screwworm in Cats

Shots: The US FDA has granted Emergency Use Authorization (EUA) to Credelio CAT (lotilaner) for the treatment of New World screwworm (NWS; Cochliomyia hominivorax) infestations in cats EUA was based on the research assessing Credelio CAT to treat Old World screwworm in cats & research on the efficacy of Credelio against New World screwworm in dogs…

ByRidhi RastogiNovember 24, 2025

NEWS

Elanco Inks a $295M Deal with Blackstone for Xdemvy’s Royalties and Milestones, Accelerating Debt Repayment

Shots: Elanco has sold certain future royalties & milestones linked to Xdemvy (0.25% lotilaner ophthalmic solution) for human use, to Blackstone Life Sciences & Blackstone Credit & Insurance to reduce its debt & strengthen its financial position As per the deal, Elanco will receive $295M in cash to repay portions of its loans on a…

ByRidhi RastogiMay 7, 2025

INSIGHTS+

Insights+: The US FDA New Drug Approvals in July 2023

Shots: The US FDA approved 5 NDAs and 2 BLA in July 2023, leading to treatments for patients and advances in the healthcare industry. The CDER and CBER approved 76 novel products in 2023 In July 2023, the major highlights drugs were Beyfortus (nirsevimab) approval for the prevention of RSV lower respiratory tract disease in…

BySenior EditorAugust 16, 2023

Elanco’s Credelio Quattro-CA1 Receives the FDA’s Conditional Approval to Treat New World Screwworm Infestations in Dogs

Elanco’s Credelio CAT (Lotilaner) Receives the US FDA’s EUA Against New World Screwworm in Cats

Elanco Inks a $295M Deal with Blackstone for Xdemvy’s Royalties and Milestones, Accelerating Debt Repayment

Insights+: The US FDA New Drug Approvals in July 2023

Contact US

OUR INFORMATION

FOLLOW US